CRISPR/Cas9 technology generated a thymine to cytosine change at position 4033 (c.4033T>C) resulting in the substitution of histidine for tyrosine at residue 1345 (p.Y1345H). This corresponds to the Y1355H missense variant identified in a family with fatty liver disease. (J:330003)